Home › Stocks › MIRM › All Fund Holders
MIRM — MIRUM PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 43 · Reported value held: $2.77B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Janus Henderson Group history | Q1 2026 | 6.79M | $627.30M | 0.31% | Add |
| BlackRock Inc history | Q2 2026 | 4.39M | $513.94M | 0.01% | Reduce |
| Vanguard Group history | Q4 2025 | 2.60M | $205.07M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 1.39M | $163.21M | 0.01% | Add |
| Invesco Ltd history | Q2 2026 | 1.36M | $159.69M | 0.01% | Add |
| Wellington Management Group history | Q2 2026 | 1.31M | $153.36M | 0.03% | Reduce |
| Capital World Investors history | Q2 2026 | 1.15M | $135.04M | 0.02% | Add |
| Franklin Resources history | Q2 2026 | 1.15M | $134.95M | 0.03% | Reduce |
| Two Sigma Investments history | Q2 2026 | 690.32K | $80.82M | 0.06% | Reduce |
| BNY Mellon history | Q2 2026 | 669.97K | $78.43M | 0.01% | Add |
| Bank of America Corp history | Q2 2026 | 561.72K | $65.76M | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 549.87K | $64.37M | 0.02% | Reduce |
| Balyasny Asset Management history | Q2 2026 | 489.17K | $57.27M | 0.07% | Reduce |
| Northern Trust Corp history | Q2 2026 | 452.04K | $52.92M | 0.01% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 449.43K | $52.61M | 0.01% | Add |
| Renaissance Technologies history | Q2 2026 | 442.19K | $51.77M | 0.07% | Reduce |
| MFS Investment Management history | Q2 2026 | 384.57K | $45.02M | 0.01% | Add |
| Norges Bank Investment Management history | Q4 2025 | 263.18K | $20.79M | 0.00% | New |
| Legal & General Investment Management America history | Q2 2026 | 159.23K | $18.64M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 3.41M | $12.62M | 0.00% | Reduce |
| Principal Global Investors history | Q2 2026 | 101.90K | $11.93M | 0.01% | Add |
| Millennium Management history | Q2 2026 | 96.21K | $11.26M | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 81.59K | $9.55M | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 74.75K | $8.75M | 0.01% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 2.20M | $8.56M | 0.00% | New |
| Arrowstreet Capital history | Q1 2026 | 67.89K | $6.27M | 0.00% | Reduce |
| AQR Capital Management history | Q2 2026 | 28.65K | $3.35M | 0.00% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 27.88K | $3.26M | 0.00% | Reduce |
| Polen Capital Management history | Q2 2026 | 20.90K | $2.45M | 0.02% | Add |
| Wells Fargo & Co history | Q2 2026 | 518.00K | $2.02M | 0.00% | Reduce |
| Prudential Financial history | Q2 2026 | 14.72K | $1.72M | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 7.70K | $901.44K | 0.00% | Reduce |
| CPP Investments history | Q1 2026 | 8.80K | $812.94K | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 218.00K | $806.05K | 0.00% | Add |
| Marshall Wace history | Q1 2026 | 4.65K | $429.57K | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 115.00K | $425.21K | 0.00% | Hold |
| Amundi US history | Q2 2026 | 3.10K | $363.38K | 0.00% | New |
| T. Rowe Price Associates history | Q2 2026 | 2.66M | $310.89K | 0.03% | Add |
| Farallon Capital Management history | Q1 2026 | 3.00K | $277.14K | 0.00% | Hold |
| Point72 Asset Management history | Q2 2026 | 2.00K | $234.14K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 1.59K | $186.02K | 0.00% | Add |
| Lazard Asset Management history | Q2 2026 | 2.67M | $98.93K | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 16.00K | $59.16K | 0.00% | Reduce |